Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Blue Jet Healthcare shares rally 9% after Rs 800 crore QIP allotment
Blue Jet Healthcare shares rose sharply on Friday after the company completed its Rs 800 crore QIP, attracting marquee institutional investors, including multiple ICICI Prudential Mutual Fund schemes. The fund raise is expected to strengthen the company's balance sheet, support expansion plans, and boost long-term growth prospects while broadening its institutional shareholder base.
Market ends higher: 3 factors that helped Sensex, Nifty snap two-day losing streak
Bharti Airtel, HDFC Bank and Sun Pharma were the biggest contributors to the Nifty's gains. The Nifty Bank index climbed 510 points to 57,252, while the Midcap index outperformed, rising 844 points to 62,167.
Stocks in news: Adani Enterprises, Cochin Shipyard, IDFC First Bank, Premier Energies, Glenmark Pharma
Markets traded subdued on the weekly expiry day, with indices ending marginally lower. Cochin Shipyard's offer for sale saw strong investor demand on its first day. Adani Enterprises' US legal case faces a likely dismissal by federal prosecutors. IDFC First Bank launched provident fund payment services through its EPFO integration. Premier Energies secured significant orders, and Glenmark Pharma launched a generic drug in the US.
Vatika Hotels refinance Rs 550 crore debt with Kotak
Vatika Hotels has refinanced Rs 550 crore debt with Kotak Mahindra Bank. This move marks the exit of India Special Assets Fund III from the company. The hotel owner experienced financial stress during the Covid-19 pandemic. Vatika Hotels' debt has significantly declined after restructuring and equity infusion. The company now holds a BBB investment-grade rating, reflecting improved financial health.
Stocks to buy or sell: Dharmesh Shah of ICICI Sec suggests buying Shriram Finance, Piramal Pharma shares on 6 July
Indian benchmark indices, Sensex and Nifty 50, opened higher on July 6, driven by gains in private banking stocks following strong quarterly updates from HDFC Bank and Axis Bank. Market breadth was positive with 14 of the 16 major indices in the green.
Analysts back buy-on-dips strategy as Nifty targets 24,450–24,800
Indian stock market analysts are optimistic, anticipating the Nifty to continue its upward trend. They suggest buying on dips around the 24,000-24,150 mark, with potential upside targets reaching 24,800. Several stocks, including Container Corporation of India, IndusInd Bank, Biocon, HDFC Asset Management Company, Shriram Finance, and Piramal Pharma, are highlighted as strong buy recommendations with specific price targets and stop-losses.
Barometers extend winning streak for 3rd session; Nifty settles above 24,250 mark
The Nifty settled above the 24,250 mark. Realty, IT and pharma shares advanced, while PSU bank, media and auto shares declined.
Sensex gains 579 points, Nifty ends above 24,150: 5 reasons why stock market rose today
Indian indices rose, Sensex up 579 pts, Nifty above 24,150, led by IT stocks, oil companies. Bank of Baroda fell on NMC Health settlement.
Healthcare, banks and EVs remain long-term bets: Invesco Mutual Fund's Taher Badshah
Taher Badshah, Chief Investment Officer at Invesco Mutual Fund, expects EV adoption to increase gradually with policy support, while opportunities are emerging in power distribution alongside transmission. Badshah also said SIP inflows remain stable and mutual fund industry trends are not showing signs of concern.
Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent Systems
Indian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving averages, with a decisive close above 24,200 crucial for further gains. Several companies like Waaree Energies, Kotak Bank, and Tata Motors are in focus due to significant developments, including US investigations, strategic partnerships, and EV expansion plans.
HDFC Mutual Fund buys additional 10 lakh shares of Global Health for Rs 130 crore
HDFC Mutual Fund has secured an additional 10 lakh shares of Global Health, which is known for operating Medanta hospitals, from co-founder Sunil Sachdeva for Rs 130 crore. This acquisition builds on a prior purchase made last month. The transaction accounts for a 0.37% stake in the company. In related news, Global Health has reported an impressive 39.7% increase in its fourth-quarter profit after tax, totaling Rs 141.7 crore.
Nifty, Bank Nifty outlook & stock recommendations by Motilal Oswal
Chandan Taparia of Motilal Oswal Financial Services expects Nifty and Bank Nifty to trade with a weak bias as long as they remain below 23,850 and 57,250, respectively.